Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion type Assertion NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_head.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion description "[Adoptive cell transfer (ACT), either using rapidly expanded tumor infiltrating lymphocytes or T-cell receptor transduced peripheral blood lymphocytes, can be considered one of the most promising approaches in cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_provenance.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion evidence source_evidence_literature NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_provenance.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion SIO_000772 20349059 NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_provenance.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion wasDerivedFrom befree-20140225 NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_provenance.
- NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_assertion wasGeneratedBy ECO_0000203 NP515721.RA6us6HB_tTx-yaBYk4_EloRJuYdfxXu_lyFSCmSwAeEo130_provenance.